Wszola Michal, Domagala Piotr, Ostaszewska Agata, Gorski Lukasz, Karpeta Edyta, Berman Andrzej, Sobol Maria, Durlik Magdalena, Chmura Andrzej, Kwiatkowski Artur
Department of General and Transplantation Surgery, The Medical University of Warsaw, Poland; Foundation of Research and Science Development, Otwock, Poland.
Department of General and Transplantation Surgery, The Medical University of Warsaw, Poland.
Transplant Proc. 2019 Oct;51(8):2514-2519. doi: 10.1016/j.transproceed.2019.02.052. Epub 2019 Aug 28.
Hypothermic machine perfusion (HMP) has become a standard method of preservation for kidneys procured from expanded-criteria donors and donors after cardiac death. There are different systems and approaches to the HMP preservation period, with cold storage prior to HMP sometimes taking several hours. This study evaluated whether the time at which kidneys receive HMP had any influence on the outcomes of kidney transplantation.
In this analysis, patient and graft survival were evaluated over a 1-year post-transplantation period. Patients who received HMP kidneys (n = 379) were divided into 2 groups: those who received kidneys with a cold ischemia time (CIT) prior to HMP <295 minutes (group G1; n = 254) and those who received kidneys with CIT prior to HMP >295 minutes (group G2; n = 125).
Delayed graft function was observed in 31.8% (81/254) of patients in group G1 vs 46.4% (58/125) of patients in group G2 (P = .007). One-year graft survival was statistically higher in the group G1 (93.2%; 233/254) vs group G2 (86.5%; 105/125, P = .029). Mean 1-year estimated glomerular filtration rate was significantly better in the group G1.
In conclusion, introduction of HMP up to 295 minutes from procurement led to better early and 1-year graft results. Kidneys should receive HMP as soon as possible after retrieval, preferably during procurement.
低温机器灌注(HMP)已成为从扩大标准供体和心脏死亡后供体获取的肾脏的标准保存方法。HMP保存期有不同的系统和方法,HMP前的冷藏有时需要数小时。本研究评估了肾脏接受HMP的时间是否对肾移植结果有任何影响。
在本分析中,评估了移植后1年的患者和移植物存活率。接受HMP肾脏的患者(n = 379)分为2组:HMP前冷缺血时间(CIT)<295分钟的患者(G1组;n = 254)和HMP前CIT>295分钟的患者(G2组;n = 125)。
G1组31.8%(81/254)的患者出现移植肾功能延迟,而G2组为46.4%(58/125)(P = .007)。G1组1年移植物存活率在统计学上高于G2组(93.2%;233/254)对比(86.5%;105/125,P = .029)。G1组的平均1年估计肾小球滤过率明显更好。
总之,在获取后295分钟内引入HMP可带来更好的早期和1年移植物结果。肾脏应在取回后尽快接受HMP,最好在获取期间。